PUBLIC CONTRACT · 2025
Aquisição de RAMUCIRUMAB IV 10MGML 50ML SOL PERF, ao abrigo do AQ 2023/491, para a ULSASI, para o ano de 2025
- Contract value
- €12,473.28
- Signed on
- 21 July 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11595180PUBLISHED SUBJECT
Aquisição de RAMUCIRUMAB IV 10MGML 50ML SOL PERF, ao abrigo do AQ 2023/491, para a ULSASI, para o ano de 2025
Parties involved
- Place of performance
- Portugal, Lisboa, Amadora
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- LILLY PORTUGAL - PRODUTOS FARMACEUTICOS · Tax ID 500165602
Values and timeline
- Contract price
- €12,473.28
- Procedure base price
- €12,473.28
- Total effective price
- Not reported on Portal BASE
- Publication date
- 21 July 2025
- Award date
- 21 July 2025
- Signing date
- 21 July 2025
- Performance period
- 163 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7736755
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.